Correlation Between 10X Genomics and HealthEquity
Can any of the company-specific risk be diversified away by investing in both 10X Genomics and HealthEquity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 10X Genomics and HealthEquity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 10X Genomics and HealthEquity, you can compare the effects of market volatilities on 10X Genomics and HealthEquity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 10X Genomics with a short position of HealthEquity. Check out your portfolio center. Please also check ongoing floating volatility patterns of 10X Genomics and HealthEquity.
Diversification Opportunities for 10X Genomics and HealthEquity
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between 10X and HealthEquity is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding 10X Genomics and HealthEquity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HealthEquity and 10X Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 10X Genomics are associated (or correlated) with HealthEquity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HealthEquity has no effect on the direction of 10X Genomics i.e., 10X Genomics and HealthEquity go up and down completely randomly.
Pair Corralation between 10X Genomics and HealthEquity
Considering the 90-day investment horizon 10X Genomics is expected to under-perform the HealthEquity. In addition to that, 10X Genomics is 2.13 times more volatile than HealthEquity. It trades about -0.08 of its total potential returns per unit of risk. HealthEquity is currently generating about 0.19 per unit of volatility. If you would invest 8,027 in HealthEquity on October 31, 2024 and sell it today you would earn a total of 2,853 from holding HealthEquity or generate 35.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
10X Genomics vs. HealthEquity
Performance |
| Timeline |
| 10X Genomics |
| HealthEquity |
10X Genomics and HealthEquity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 10X Genomics and HealthEquity
The main advantage of trading using opposite 10X Genomics and HealthEquity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 10X Genomics position performs unexpectedly, HealthEquity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HealthEquity will offset losses from the drop in HealthEquity's long position.| 10X Genomics vs. Twist Bioscience Corp | 10X Genomics vs. Fate Therapeutics | 10X Genomics vs. Beam Therapeutics | 10X Genomics vs. Veracyte |
| HealthEquity vs. Ollies Bargain Outlet | HealthEquity vs. Appfolio | HealthEquity vs. Grand Canyon Education | HealthEquity vs. Globus Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |